881 – Prognostic Factors of Physical Function Decline in the PREPARE Study
Background The Pitavastatin to REduce Physical Function Impairment and FRailty in HIV (PREPARE) substudy of REPRIEVE found small declines in physical function, and no evidence of pitavastatin effect. However, there was substantial individual variability, with some participants experiencing considerable declines. The purpose of this pre-specified exploratory analysis was to identify participants at a greater risk…